McMaster researchers say resistance successful pathway discovering new antibiotic drugs

Antibiotic resistance, a successful pathway for new drugs

8:09 AM, 15th October 2013
McMaster university research news
From left Gerry Wright with members of his lab involved in the study.

HAMILTON, CANADA: In the battle against antibiotic resistant bacteria, McMaster researchers have found resistance itself is a successful pathway for discovering new antibiotic drugs. “In essence, we’ve made resistance useful instead of a scary problem,” said Gerry Wright, Professor and Scientific director of the Michael G DeGroote, Institute for Infectious Disease Research.

Last month, the Centres for Disease Control and Prevention in the United States warned that the overuse of antibiotics in medicine and agriculture has fostered germs that are resistant to every known antibiotic, causing infections for which there is no treatment. Coupled with this, there has been a drastic decline in the number of new antibiotics developed in the last 25 years.

According to Wright, the challenge in discovering new antibiotics is finding the source of new chemicals that may have antibiotic properties. Most of today’s antibiotics were discovered between 1940 and 1960, when bacteria and fungi that grow in the environment were screened. Penicillin and many anticancer drugs were discovered this way.

“It turns out that bacteria that live in the soil are great producers of antibiotics and other medicine,” said Wright, adding many agree that soil bacteria and fungi are still the best source of new drug candidates. However, the challenge of collecting and testing millions of strains to find new lead compounds for potential new antibiotics is like trying to find a needle in a haystack, he explained.

Researchers in Wright's lab wondered if there was another way to run screens (a drug discovery process) to tackle this problem.

“We questioned what would happen if we applied resistance as a filter to find new drug candidates. We were surprised when we noticed a dramatic increase in the ‘hit rate’ by reducing the size of the haystack,” said Maulik Thaker, Postdoctoral Researcher, who led a study on this process.

The new procedure let researchers screen for new drugs 10,000 times more effectively than in the past. Researchers discovered - a new antibiotic called pekiskomycin from a new soil bacteria obtained from Pekisko, Alberta; new producers of antibiotics called rifamycins; new therapeutics, such as an anti-cancer compound called qeldanamycin.

The team also designed tests that let researchers distinguish between different types of antibiotic subgroups. Using snippets of DNA that code for known classes of drugs and sophisticated new software programme, they construct patterns that identify strains of soil bacteria that may be producing new antibiotic and anticancer compounds.

The implications are significant, said Thaker.

According to Thaker, the implications are significant because pharmaceutical companies are reluctant to invest in new antibiotics due to the significant cost of drug development and a drug’s short lifespan caused by antibiotic resistance.

“But we can offer a way to zero in on a handful of drug producing strains of soil bacteria instead of sifting through tens of thousands, or millions. Then, it becomes a viable business model for finding new molecules more rapidly,” he added.

© McMaster University News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Towards development of dye-based solar cells

WISCONSIN, US: UW-Madison researchers working at the intersection of basic and applied science focus on key factors like cost, environmental impacts . ...

Read more
China to punish 72 companies for violating environmental protection regulations

BEIJING, CHINA: China’s environmental watchdog has named the 72 companies that have violated environmental protection regulations. The Chinese M ...

Read more
Newly developed process for foam-like polymer coatings

ROCHESTER, US: Polymers, the essential component of plastics, are found in countless commercial, medical, and industrial products. Polymers that are p ...

Read more
Oman Oil to acquire Oxea from Advent International

MUSCAT, OMAN: The Oman Oil Company agreed to buy German chemicals maker Oxea from buyout firm Advent International to expand into downstream activitie ...

Read more
Gelatin can replace platinum in fuel cells, finds new study

BIRMINGHAM, UK: New research by researchers at University of Birmingham has found that a substance made from gelatin could be used to replace platinum ...

Read more
Clariant expands dehydrogenation catalysts capacity in Kentucky, US

MUTTENZ, SWITZERLAND: Clariant, a world leader in specialty chemicals, has successfully expanded production capacity for Houdry dehydrogenation cataly ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X